Status:
RECRUITING
Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia
Lead Sponsor:
University Hospital, Caen
Conditions:
Regional Anesthesia Morbidity
Cesarean Section Complications
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
General anesthesia during pregnancy is associated with several major risks including unanticipated difficult airway, pulmonary aspiration, and specific anesthetic effects on the newborn. Thus, intrath...
Detailed Description
The present controlled randomized double blind trial was designed to compare 2 intrathecal dose of bupivacaine for cesarean section * a "standard" dose of 10 mg of intrathecal bupivacaine associated ...
Eligibility Criteria
Inclusion
- scheduled cesarean section with intrathecal anesthesia
- term pregnancy \> 35 weeks
- signed informed consent
Exclusion
- unscheduled or emergent cesarean section
- any contra indication to intrathecal anesthesia
- any antihypertensive drug prescribed to control arterial pressure during pregnancy
- pre-eclampsia and eclampsia
- history of Marfan or Ehlers Danlos disease
Key Trial Info
Start Date :
February 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05233462
Start Date
February 23 2022
End Date
December 31 2026
Last Update
July 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen University Hospital
Caen, France